The Interactions of Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases
Authors:
- Hugo PerazzoHPHugo Perazzo
- Thierry PoynardTPThierry Poynard
- Jean-François DufourJDJean-François Dufour
- 1 February 2014
- journal article
- research article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 18 (1) , 233-248
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Nonalcoholic Fatty Liver Disease Increases Risk of Death Among Patients With Diabetes: A Community-Based Cohort StudyAmerican Journal of Gastroenterology, 2010
- Effects of Combination Lipid Therapy on Coronary Stenosis Progression and Clinical Cardiovascular Events in Coronary Disease Patients With Metabolic Syndrome: A Combined Analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)The American Journal of Cardiology, 2009
- Pathogenesis of non-alcoholic fatty liver diseaseQJM: An International Journal of Medicine, 2009
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2009
- Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesityProceedings of the National Academy of Sciences, 2009
- Long-Term Follow-Up of Patients With Nonalcoholic Fatty LiverClinical Gastroenterology and Hepatology, 2009
- Hepatic Steatosis and Subclinical Cardiovascular Disease in a Cohort Enriched for Type 2 Diabetes: The Diabetes Heart StudyAmerican Journal of Gastroenterology, 2008
- Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort StudyAmerican Journal of Gastroenterology, 2008
- The NAFLD fibrosis scoreHepatology, 2007
- Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver diseaseHepatology, 2005